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Abstract To conduct a comparison of the diagnostic
performance of exercise bicycle testing and single-
photon emission computed tomography (SPECT) with
computed tomography coronary angiography (CTCA)
for the detection of obstructive coronary artery disease
(CAD) in patients with stable angina. 376 symptomatic
patients (254 men, 122 women, mean age
60.4 ± 10.0 years) referred for noninvasive stress
testing (exercise bicycle test and/or SPECT) and
invasive coronary angiography were included. All
patients underwent additional 64-slice CTCA. The
diagnostic performance of exercise bicycle testing (ST
segment depression), SPECT (reversible perfusion
defect) and CTCA (C50% lumen diameter reduction)
was presented as sensitivity, specificity, positive and
negative predictive value (PPV and NPV) to detect or
rule out obstructive CAD with quantitative coronary
angiography as reference standard. Comparisons of
exercise bicycle testing versus CTCA (n = 334), and
SPECT versus CTCA (n = 61) were performed. The
diagnostic performance of exercise bicycle testing was
significantly (P value \ 0.001) lower compared to
CTCA: sensitivity of 76% (95% CI, 71–82) vs. 100%
(95% CI, 97–100); specificity of 47% (95% CI, 36–58)
vs. 74% (95% CI, 63–82). We observed a PPV of 70%
(95% CI, 65–75) vs. 91% (95% CI, 87-94); and NPV of
30% (95%, 25–35) vs. 99% (95%, 90–100). There was
a statistically significant difference in sensitivity
(P value \ 0.05) between SPECT and CTCA: 89%
(95% CI, 75–96) vs. 98% (95% CI, 87–100); but not in
specificity (P value [ 0.05): 77% (95% CI, 50–92) vs.
82% (95% CI, 56–95). We observed a PPV of 91%
(95% CI, 77–97) vs. 93% (95% CI, 81–98); and NPV of
72% (95%, 46–89) vs. 93% (95%, 66–100). SPECT
and CTCA yielded higher diagnostic performance
compared to traditional exercise bicycle testing for the
detection and rule out of obstructive CAD in patients
with stable angina.
Keywords Exercise bicycle testing  Single-photon
emission computed tomography  SPECT  Computed
tomography coronary angiography  CT  Diagnostic
accuracy
Introduction
Exercise bicycle testing represents a widely available
and inexpensive diagnostic modality and was part of
the initial assessment in 76% of patients with
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suspected angina in the Euro Heart Survey [1].
However, exercise bicycle testing is limited in the
prediction of adverse events with a reported 47% of
events occurring during follow-up in patients with a
negative exercise bicycle test result [2]. Nuclear
myocardial perfusion imaging (MPI) using single-
photon emission computed tomography (SPECT)
allows the noninvasive assessment of the hemody-
namic significance of coronary artery stenoses by the
detection of myocardial ischemia and provides com-
plementary information for risk stratification [3].
Computed tomography coronary angiography
(CTCA) has rapidly emerged as an alternative nonin-
vasive modality for the diagnosis of CAD. The
diagnostic performance of CTCA on a per patient
level is high with sensitivities ranging from 93 to 100%
and specificity ranging from 82 to 96%. In particular,
CTCA yields a high negative predictive value to
reliable rule out of the presence of significant coronary
stenosis [4]. Similar to nuclear MPI, recent studies
reported the incremental value of CTCA in predicting
all-cause mortality in symptomatic patients [5, 6].
In this study, we performed a comparison of the
diagnostic performance of exercise bicycle testing
with CTCA, and SPECT with CTCA, respectively, to
detect obstructive coronary artery disease using
invasive coronary angiography (ICA) as the standard
of reference.
Methods
Study design
We evaluated 376 symptomatic patients (254 men; 122
women, mean age 60.4 ± 10.0) who were referred for
stress testing (exercise bicycle test and/or SPECT) and
ICA based on gender, age, type (typical, atypical or
nonanginal) and severity of chest pain. Typical angina
was defined when the following three characteristics
were present: (1) sub-sternal discomfort (2) precipi-
tated by physical exertion or emotion and (3) relieved
with rest or nitroglycerine within 10 min. Atypical
angina pectoris was defined when only two out of these
three symptom characteristics were met. Nonanginal
chest pain was defined when only one was met or
absence of the described symptoms.
All patients underwent additional CTCA irrespec-
tive of the clinical judgment and stress test outcome
as part of a running research protocol. The study
protocol was approved by the institutional review
board of the Erasmus University Medical Center and
informed consent was obtained in all patients.
Patient population
The study population was obtained from July 2004
until September 2008. Patients with acute coronary
syndromes, previous history of percutanous coronary
stent placement, coronary artery bypass surgery and
prior myocardial infarction were excluded from the
study.
Specific CT related exclusion criteria were impaired
renal function (serum creatinine [120 lmol/L), per-
sistent arrhythmias, inability to perform a breath hold
of 15 s, or known allergy to Iodinated contrast
material.
Exercise bicycle test
Patients underwent exercise bicycle testing in the
absence of contraindications (left bundle branch block,
paced rhythm, the Wolff-Parkinson-White syndrome,
left ventricle hypertrophy, electrolyte imbalance,
intraventricular conduction abnormalities, use of dig-
italis, or severe aortic stenoses [7]. The exercise
bicycle test was interpreted blinded to the CTCA and
ICA findings. The exercise bicycle test result was
considered positive if the electrocardiogram showed
horizontal or down-sloping ST-segment depression or
elevation [C1 mm (0.1-mV) for C60–80 ms after the
end of the QRS complex] [7]. The exercise bicycle test
result was considered equivocal if ischemic ST
depression was absent but heart rate did not reach
85% of the maximum predicted for age and gender, if
nondiagnostic ST-segments were present during exer-
cise (0.5- to 0.9-mm horizontal ST-segment depres-
sion, ST-segment depression with slight upslope,
baseline ST-segment and T-wave abnormalities with
nondiagnostic changes on stress) or exercise capacity
was limited [7, 8].
Single-photon emission computed tomography
(SPECT)
SPECT image acquisition and reconstruction was
performed as described previously [9]. A dose of
370 MBq of 99mTc-sestamibi (Cardiolite; Bristol-
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was administered intravenously approximately 1 min
prior to termination of the stress test. The perfor-
mance of SPECT was evaluated based on achieve-
ment of target heart rate (85% of the maximum
predicted for age and gender); horizontal or down-
sloping ST-segment depression or elevation [C1 mm
(0.1-mV) for C60–80 ms after the end of the QRS
complex]; severe angina or clinically important
changes in blood pressure or heart rhythm.
For studies performed with the patient at rest,
370 MBq of sestamibi was injected at least 24 h after
the stress test. Single-photon emission computed
tomography (SPECT) images were acquired with a
Gammasonics single-head Rota camera (Orbiter;
Siemens, Iselin, NJ) without attenuation or scatter
correction, by using a low-energy all-purpose colli-
mator. Image acquisition and reconstruction were
performed as earlier described [9]. The SPECT
images were interpreted blinded to the CTCA and
ICA findings. A reversible perfusion defect was
defined as a perfusion defect on stress images that
partially or completely resolved at rest. A fixed
perfusion defect was defined as a perfusion defect on
stress images that persisted on rest images. Findings
were considered as abnormal in the presence of a
fixed and/or reversible perfusion defect.
Computed tomography coronary angiography
(CTCA)
The first enrolled patients (n = 119) underwent
64-slice CTCA (Sensation 64, Siemens Healthcare,
Forchheim, Germany) from October 2004 to March
2006. Patients with a heart rate exceeding 65 bpm
received either additional oral or intravenous beta-
blockers. The subsequent 257 patients underwent
dual-source CTCA (Definition, Siemens Healthcare,
and Forchheim, Germany) from April 2006 to
September 2008. Patient preparation, scan protocol
and image reconstruction algorithm for 64-slice and
dual-source CT scanners are presented in the Appen-
dix Table. The CTCA images were interpreted
blinded to the results of the stress test or ICA.
Segments distal to a chronic total occlusion were
excluded. Segments were scored as having obstruc-
tive CAD if there was C50% diameter reduction of
the lumen by visual assessment.
Invasive coronary angiography (ICA)
Four experienced cardiologists, unaware of the
results of the stress test or CTCA, analyzed all
coronary segments using a modified 17-segment
AHA classification [10]. Segments were visually
classified as normal (smooth parallel or tapering
borders; visually less than 20% narrowing) or as
having non-significant or significant coronary
obstruction (visually more than 20% narrowing).
The stenoses visually scored as having more than
20% narrowing were quantified by a validated
quantitative coronary angiography (QCA) algorithm
(CAAS, Pie Medical, Maastricht, the Netherlands)
and classified as significant if the lumen diameter
reduction exceeded C50%.
Statistical analysis
Statistical analyses were performed using SPSS (ver-
sion 12.1. SPSS Inc Chicago Ill. USA). Categorical
patients’ demographics and characteristics were
expressed as numbers and percentages. Continuous
variables were expressed as mean (standard deviation).
The pretest probability of having obstructive CAD
was calculated using the Duke Clinical Score, which
includes types of chest discomfort, age, gender and
traditional risk factors [11] and was expressed as
mean (standard deviation).
Diagnostic performance and predictive value of
exercise bicycle testing, SPECT and CTCA for the
diagnosis of obstructive CAD compared to the
reference standard was evaluated on a per patient
level and expressed as sensitivity, specificity, positive
and negative predictive value (PPV and NPV) and
their corresponding 95% confidence intervals, and
positive and negative likelihood ratios (LR).
Four comparisons were performed; exercise bicy-
cle testing (conclusive outcome) versus CTCA;
exercise bicycle testing (conclusive outcome) and
SPECT versus CTCA; exercise bicycle testing (con-
clusive and inconclusive outcome) versus CTCA; and
SPECT versus CTCA. An intention to diagnose
design was used: in patients with an inconclusive
exercise bicycle test outcome without further testing,
the test was scored as a positive outcome. In patients
with inconclusive exercise bicycle test outcome with
subsequent SPECT, both test results were indepen-
dently evaluated in the analysis of the diagnostic
Int J Cardiovasc Imaging (2012) 28:675–684 677
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performance of exercise bicycle test (conclusive
outcome) and SPECT, respectively.
The area under the receiver operating characteris-
tic (ROC) curve, the c-index, was calculated for EBT
(conclusive outcome), EBT (conclusive and incon-
clusive outcome), EBT (conclusive outcome) and
SPECT, SPECT and CTCA.
The McNemar test was performed to compare the
sensitivities and specificities for CTCA versus exer-
cise bicycle testing (conclusive outcome), exercise
bicycle testing (conclusive outcome) and SPECT,
exercise bicycle testing (conclusive and inconclusive
outcome) and SPECT, respectively. Additional agree-
ment analyses between the four comparisons were
performed with ICA as reference standard.
Results
Patient demographics (n = 376) are listed in Table 1.
The mean pretest probability was 61 ± 30%. A total
of 334 (89%, 334/376) enrolled patients underwent
exercise bicycle testing and 258 (77%, 258/334)
patients demonstrated a conclusive outcome. In 76
(23%, 76/334) patients, exercise bicycle testing was
inconclusive and 19 (25%, 19/76) patients were
subsequently referred to SPECT. In the remaining 57
(75%, 57/76) patients with inconclusive exercise
bicycle testing without further testing, the test result
was scored as positive for CAD. A total of 42 (11%,
42/376) enrolled patients were directly referred to
SPECT. SPECT outcome was conclusive in all
patients.
Diagnostic performance
The overall prevalence of disease was 73% (276/
376). ICA showed absence of disease in 10% (39/
376), nonsignificant disease in 16% (61/376), single-
vessel disease in 36% (135/376) and multi-vessel
disease in 38% (141/376) of patients.
The diagnostic performance for the detection of
obstructive CAD on a per patient level with QCA as
standard of reference is presented in Table 2.
In patients with a conclusive exercise bicycle
testing (n = 258), sensitivity of CTCA (99%) was
significantly (P value \ 0.001) higher than of exer-
cise bicycle testing (72%). No significant difference
(P value = 0.082) was found for specificity between
the two modalities: 57% for exercise bicycle testing
and 71% for CTCA. Including patients with incon-
clusive exercise bicycle testing (n = 334) both
sensitivity and specificity were significant (P value
\ 0.001) higher for CTCA compared to exercise
bicycle testing: 100 and 74% for CTCA, respectively,
and 76 and 47% for exercise bicycle testing (conclu-
sive and inconclusive outcome), respectively. In
patients with a conclusive stress test (exercise bicycle
testing or SPECT; n = 319) the sensitivity was
significant higher (P value \ 0.001) for CTCA
(99%) compared to the stress test, exercise bicycle
testing or SPECT (75%). There was no significant
difference (P value = 0.07) in specificity between
CTCA and stress test: 74 and 61% respectively. In
patients who underwent SPECT (n = 61) a signifi-
cant difference was found for sensitivity
(P value = 0.021), but not for specificity
(P value = 1.0) between SPECT and CTCA. Sensi-
tivity was 89 and 98% for SPECT and CTCA,
respectively. Specificity was 77 and 82% for SPECT
and CTCA, respectively.
Table 1 Patient demographics (n = 376)
N 376
Typical angina 191 (50)
Atypical angina 92 (25)
Nonanginal chest pain 92 (25)
Men 254 (68)
Age (years)a 60.4 ± 10.0
BMI (kg/m2)a 27.3 ± 4.1
Risk factors
Hypertensionb 170 (45)
Hypercholesterolemiac 199 (53)
Diabetes mellitusd 56 (15)
Smoker 88 (23)
Family history of CADe 64 (17)
Obesityf 79 (21)
Values are n (%) unless otherwise indicated
a Mean and standard deviation
b Blood pressure 140/90 mm Hg or treatment for hypertension
c Total cholesterol [ 180 mg/dL or treatment for
hypercholesterolemia
d Treatment with oral antidiabetic medication or insulin
e Family history of coronary artery disease (CAD), having
first- or second-degree relatives with premature CAD (age \
55 years)
f Body mass index (BMI) 30 kg/m2
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Agreement analysis
The agreement between exercise bicycle testing and
CTCA, and SPECT and CTCA, respectively, with
ICA as reference standard is presented in Table 3.
Exercise bicycle test and CTCA
In patients who underwent exercise bicycle testing
(conclusive and inconclusive outcome), there was
agreement with CTCA in 72% of patients (239/334).
The agreement between a true positive exercise bicycle
test and CTCA outcome was 76% (187/246) in the
presence of obstructive CAD at ICA. The agreement
between a true negative exercise bicycle test and
CTCA outcome was 39% (35/88) in the absence of
obstructive CAD at ICA. In patients with a false
negative exercise bicycle test outcome, the presence of
obstructive CAD was correctly demonstrated by a
positive CTCA in all patients (100%, 58/58). A
negative CT scan correctly ruled out the presence of
CAD in 64% (30/47) of patients with a false-positive
exercise bicycle test outcome. Exercise bicycle testing
correctly identified one patient with obstructive CAD
and 6 patients without obstructive CAD, respectively,
who were misdiagnosed with CTCA.
SPECT and CTCA
In patients who underwent SPECT, there was agree-
ment with CTCA in 85% of patients (52/61). The
agreement between a true positive SPECT and CTCA
was 86% (38/43) in the presence of obstructive CAD at
ICA. The agreement between a true negative SPECT
and CTCA was 86% (12/14) in the absence of
obstructive CAD at ICA. In 5 patients with a false
negative SPECT outcome, the presence of obstructive
CAD was correctly demonstrated by a positive CTCA
in all patients. A negative CT scan correctly ruled out
the presence of CAD in two patients with a false-
positive SPECT outcome. SPECT correctly identified
one patient with obstructive CAD who was misdiag-
nosed with CTCA.
Discussion
The diagnosis of ischemia remains challenging and
extensive effort is invested to improve theT
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noninvasive diagnostic work-up and selection of
patients in need for catheterization and possible
percutanous catheter treatment. Stress testing prior to
percutanous coronary intervention has been associ-
ated with shorter hospital stays, and lower rates of
revascularization without adverse effects on cardiac
death or myocardial infarction [12, 13].
For reasons of availability and costs, traditionally,
exercise ECG using treadmill or bicycle testing
represents the first-line test to diagnose inducible
ischemia in patients presenting with anginal com-
plaints. Exercise bicycle testing should be conducted
in patients not taking anti-ischemic drugs, but this
may not always be possible or considered safe [7].
Exercise bicycle testing is not of diagnostic value in
the presence of a left bundle branch block, paced
rhythm and Wolff-Parkinson-White syndrome that
prevent reliable evaluation of the ECG changes
during stress. Lower specificity and positive
predictive value are reported in patients with resting
ECG abnormalities, in the presence of left ventricle
hypertrophy, electrolyte imbalance, or intraventricu-
lar conduction abnormalities and digitalis use. The
exercise bicycle test is less sensitive and specific in
women, in detecting single vessel disease, right
coronary or circumflex artery disease, and in the
presence of serial stenoses or extensive collaterals
[14].
Nuclear MPI using SPECT has several advantages
over exercise bicycle testing including superior
diagnostic performance [7], quantification and local-
ization of areas of ischemia, and incremental value
for risk stratification [9]. Despite the introduction of
X-ray-based attenuation correction and gated scan-
ning, SPECT remains susceptible to a variety of
artefacts (respiratory motion, spill-over from gut or
liver activity) resulting in low PPV for identifying
areas of ischemia in need for revascularization.
Table 3 Agreement analysis between CTCA and exercise bicycle test, and CTCA and SPECT (patient based analysis)
N = 258 Exercise bicycle test (conclusive outcome)
TP TN FP FN
CTCA TP (n = 194) 139 55
TN (n = 45) 30 15
FP (n = 18) 6 12
FN (n = 1) 1 0
N = 319 Exercise bicycle test (conclusive outcome) and SPECT
CTCA TP TN FP FN
TP (n = 237) 177 60
TN (n = 59) 42 17
FP (n = 21) 7 14
FN (n = 2) 2 0
N = 61 SPECT
TP TN FP FN
CTCA TP (n = 43) 38 5
TN (n = 14) 12 2
FP (n = 3) 1 2
FN (n = 1) 1 0
N = 334 Exercise bicycle test (conclusive and inconclusive outcome)
TP TN FP FN
CTCA TP (n = 245) 187 58
TN (n = 65) 35 30
FP (n = 23) 6 17
FN (n = 1) 1 0
N indicates number, TP true positives, TN true negatives, FP false positives, FN false negatives, NPV negative predictive value,
SPECT single photon emission computed tomography
680 Int J Cardiovasc Imaging (2012) 28:675–684
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CTCA allows direct visualization of the coronaries
and numerous studies have demonstrated a high
diagnostic performance of CTCA in selected patient
populations [4]. The high NPV (range 95–100%)
permits CTCA to act as reliable gate keeper to
discharge patients from further testing. The current
drawback of CTCA is the insufficient spatial resolu-
tion resulting in lower PPV in particular in the
presence of calcium.
We performed a comparison of exercise bicycle
testing with CTCA, and SPECT with CTCA, respec-
tively, using ICA as reference standard. The number
of inconclusive exercise bicycle test results (23%) is
in line with reported values in literature [15]. The
sensitivity of exercise bicycle testing (72–76%) is
similar to outcome of a large meta-analysis (sensi-
tivity 68%, specificity 77%) [16], specificity is lower
(47–57%). Dewey et al. [17] presented comparable
results in a head-to-head comparison of exercise ECG
and MSCT in 80 patients.
We found that SPECT and CTCA yielded a high
diagnostic performance (sensitivity of 89 and 98%;
specificity of 77 and 82%) that was superior to
exercise bicycle testing (sensitivity 76%, specificity
47%). We observed a reasonable agreement (76%)
between a true positive exercise bicycle testing and
CTCA and only a fair agreement (39%) was found
between a true negative exercise bicycle testing and
CTCA. The agreement was good (86%) between a
true positive SPECT and CTCA and between a true
negative SPECT and CTCA.
Our results are partly in line with reported studies
on comparison between SPECT and CTCA that
showed a good agreement (range 86–96%) in the
absence of obstructive CAD [18–20]. However, these
studies demonstrated a lower agreement (range
50–67%) for the detection of lesions with CTCA
that induced myocardial perfusion defects. The
discrepancies in agreement should be interpreted in
the context of the pretest risk of disease and the
standard of reference. Furthermore, the standard of
reference ICA was not used in all patients with the
exception of one study [18].
Which modality will represent the first-line test in
the diagnostic work-up of patients with stable angina
is largely unknown and depends on its relative costs
and availability, the pretest risk of disease in the
cohort to be examined, and the number of patients
that can be identified as not needing further
evaluation. Notably, with the advent of noninvasive
cardiac imaging testing, cumulative patient dose may
become considerably high.
The exercise bicycle test is widely availably, not
costly and safe compared to SPECT and CTCA, and
despite its inferior diagnostic performance, may
represent the first line test in patients with a low
pretest risk. SPECT and CTCA have superior diag-
nostic performance, but are associated with higher
costs and radiation exposure, and may represent more
appropriate initial tests in patients with an interme-
diate to high pretest risk.
In patients with stable angina, both normal CTCA
and SPECT have a low risk of hard coronary events
(cardiac death or nonfatal myocardial infarction)
obviating the need for catheterization or further
testing [5, 9].
SPECT as initial test may identify jeopardized
ischemic myocardium on a per patient level [38],
which fulfills the recommendations of the guidelines
prior to revascularization. However, several studies
indicated that SPECT only moderately guides revas-
cularization treatment of the ischemia-related vessel
[21–23]. CTCA could add valuable information to
MPI by allocating perfusion defects to specific
epicardial coronary vessels. However, there is a
known discrepancy in hemodynamic significance of
intermediate lesions with a luminal diameter stenosis
between 40 and 70% [18, 24]. Previous reports have
demonstrated that the anatomical assessment of a
stenosis as determined by ICA or CTCA correlates
poorly with the hemodynamic significance of inter-
mediate coronary stenoses as measured by invasive
fractional flow reserve (FFR) [24–26]. Luminal
diameter stenosis measurement does not always
reflect coronary artery resistance as it neglects
specific lesion characteristics, vasomotor tone or
presence of coronary collateral flow that may signif-
icantly affect myocardial perfusion [27]. Individual
variations in coronary anatomy may also contribute
to inadequate allocation of perfusion defects to
corresponding coronary arteries [20].
On the other hand, in case of multivessel disease
lack of perfusion defects at SPECT in patients with
obstructive lesions at ICA may be attributed to a
balanced reduction in myocardial perfusion owing to
the compromised coronary vasodilator reserve in
territories supplied by angiography stenoses and
thereby reducing the heterogeneity of flow between
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‘‘normal’’ and ‘‘abnormal’’ zones [28]. In addition,
the absence of epicardial coronary stenosis in the
presence of a perfusion defect may be caused by
microvascular dysfunction. At present, CTCA serves
as a reliable rule-out test for the presence of
significant CAD. Combined noninvasive anatomical
and functional imaging may best identify patients
who are likely to benefit most from secondary
prevention and optimal medical therapy (no or mild
ischemia present) or who may be candidates for
coronary revascularization (moderate to severe ische-
mia present).
The potential of 2D/3D image fusion techniques or
hybrid scanners (SPECT/CT) to correctly link coro-
nary stenoses at CTCA to perfusion defects to resolve
inadequate allocation of perfusion defects is now
being explored. The clinical application of cardiac
hybrid imaging was hampered due to the associated
high radiation exposure to the patient (up to 40 mSv)
[48] but technical advances now permit hybrid
imaging below 3 mSv with low-dose CTCA using
prospective ECG triggering combined with stress-
only SPECT [29].
Further investigation is needed to evaluate the
diagnostic performance of SPECT/CT to accurately
allocate and guide treatment of the target vessel.
Limitations
For the comparison SPECT versus CTCA, analyses
were limited to small sample size.
The possibility of referral bias may occur when
patients are referred to the reference test based on the
results of the noninvasive test under investigation.
Sensitivity may be inflated and specificity deflated if
patients with a positive test result are more likely to
be verified.
We performed a single center study and the
influence of local practice and referral patterns,
technical capabilities for performance of each modal-
ity may vary from institution to institution.
Conclusions
SPECT and CTCA yielded a higher diagnostic
performance compared to traditional exercise bicycle
testinging for the detection and rule out of obstructive
CAD in patients with stable angina. Future studies are
needed to evaluate the clinical value of traditional
noninvasive diagnostic tests compared to new test
such as CTCA or hybrid CTCA/SPECT taking into
account the pretest risk, availability, radiation expo-
sure and cost-effectiveness.
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Appendix
See Table 4.
Table 4 CTCA protocol
Patient preparation 64-slice CTa Dual-source CTb
Betablockers (dose, oral) Yes No
Lorazepam (dose, oral) Yes No
Nitroglycirine (0.4 mg/dose, sublingual) No Yes
Scan parameters
No. of tubes 1 2
No. of detectors 32 9 2–64 32 9 2–64
Collimation (mm) 32 9 2 9 0.6 mmc 32 9 2 9 0.6 mmc
Gantry rotation time (ms) 330 330
Effective temporal resolution (ms) 165 msd 83 msd
Pitch 0.20 0.20–0.53
kV 120 120
Full tube current (mA) 800–900 625
ECG pulsing Yes Yes
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